Dermaseptin-AC

General Information


DRACP ID  DRACP04243

Peptide Name   Dermaseptin-AC

Sequence  GMFTNMLKGIGKLAGKAALGAVKTLA

Sequence Length  26

UniProt ID  Not available

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C115H201N31O30S2

Absent amino acids  CDEHPQRSWY

Common amino acids  AG

Mass  300831

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  12

Net charge  4

Boman Index  1609

Hydrophobicity  65.38

Aliphatic Index  105.38

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34908502

Title  In Vitro and In Vivo Studies on the Antibacterial Activity and Safety of a New Antimicrobial Peptide Dermaseptin-AC

Doi Not available

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18625

DRACP is developed by Dr.Zheng's team.